Antigenic oscillations and shifting immunodominance in HIV-1 infections

Martin A. Nowak, Robert M. May, Rodney E. Phillips, Sarah Rowland-Jones, David Lalloo, Steven McAdam, Paul Klenerman, Britta Köppe, Karl Sigmund, Charles R.M. Bangham, Andrew J. McMichael

Research output: Contribution to journalArticlepeer-review

302 Citations (Scopus)

Abstract

ATYPICAL protein antigen contains several epitopes that can be recognized by cytotoxic T lymphocytes (CTL), but in a characteristic antiviral immune response in vivo, CTL recognize only a small number of these potential epitopes, sometimes only one1-2, this phenomenon is known as immunodominance1-10. Antigenic variation within CTL epitopes has been demonstrated for the human immunodeficiency virus HIV-1 (ref. 11) and other viruses12-7 and such 'antigenic escape' may be responsible for viral persistence. Here we develop a new mathematical model that deals with the interaction between CTL and multiple epitopes of a genetically variable pathogen, and show that the nonlinear competition among CTL responses against different epitopes can explain immunodominance. This model suggests that an antigenically homogeneous pathogen population tends to induce a dominant response against a single epitope, whereas a heterogeneous pathogen population can stimulate complicated fluctuating responses against multiple epitopes. Antigenic variation in the immunodominant epitope can shift responses to weaker epitopes and thereby reduce immuno-logical control of the pathogen population. These ideas are consistent with detailed longitudinal studies of CTL responses in HIV-1 infected patients. For vaccine design, the model suggests that the major response should be directed against conserved epitopes even if they are subdominant.
Original languageEnglish
Pages (from-to)606-611
Number of pages6
JournalNature
Volume375
Issue number6532
DOIs
Publication statusPublished - 1 Jan 1995
Externally publishedYes

Fingerprint

Dive into the research topics of 'Antigenic oscillations and shifting immunodominance in HIV-1 infections'. Together they form a unique fingerprint.

Cite this